Dallas, TX -- (SBWIRE) -- 11/19/2010 -- SandlerResearch announce Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Original Source : Head and Neck Cancer Market
http://www.sandlerresearch.org/reports/15789-head-and-neck-cancer-drug-pipeline-analysis-and-market-forecast.html
Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html
Browse complete Report at : Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.sandlerresearch.org/reports/15789-head-and-neck-cancer-drug-pipeline-analysis-and-market-forecast.html
GlobalData, the industry analysis specialist’s new report, “Head and Neck Cancer – Pipeline Assessment and Market Forecast to 2017” is an essential source of information and analysis on the global head and neck cancer market. The report identifies the key trends shaping and driving the global head and neck cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global head and neck cancer sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
The scope of the report includes:
Annualized global head and neck cancer market revenues data from 2001 to 2009, forecast forward for 8 years to 2017.
Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
Analysis of the current and future market competition in the global head and neck cancer market.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with head and neck cancer
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global head and neck cancer market.
Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global head and neck cancer market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global head and neck cancer market landscape? – Identify, understand and capitalize.
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Head and Neck Cancer Market: Introduction 6
2.1 GlobalData Pipeline Report Guidance 6
3 Head and Neck Cancer Market: Market Characterization 7
3.1 Head and Neck Cancer Market Size 7
3.2 Head and Neck Cancer Market Forecast and CAGR 8
3.3 Drivers and Barriers for Head and Neck Cancer Market 9
3.3.1 Drivers for Head and Neck Cancer Market 9
3.3.2 Barriers for Head and Neck Cancer Therapeutics Market 10
3.4 Opportunity and Unmet Need 10
3.5 Key Takeaway 12
4 Head and Neck Cancer Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profile for the Major Marketed Products in the Head and Neck Cancer Market 14
4.3.1 Erbitux (cetuximab) 14
4.3.2 Taxotere (docetaxel) 16
4.4 Approved Gene Therapies in China 17
4.4.1 Oncorine (H101, Modified Adenovirus) 17
4.4.2 Gendicine (Recombinant Human Ad-P53) 17
4.5 Key Takeaway 18
5 Head and Neck Cancer Market: Pipeline Assessment 19
5.1 Overview 19
5.2 Strategic Pipeline Assessment 19
5.2.1 Technology Trends Analytic Framework 19
5.3 Head and Neck Cancer Therapeutics – Promising Drugs under Clinical Development 21
5.4 Molecule Profile for Promising Drugs under Clinical Development for Head and Neck Cancer 22
5.4.1 Tykerb/ Tyverb (Lapatinib Ditosylate) 22
5.4.2 Reolysin 23
5.4.3 Oncovex 24
5.4.4 Nimotuzumab 25
5.5 Head and Neck Cancer Therapeutics Market – Clinical Pipeline by Mechanism of Action 27
5.6 Head and Neck Cancer Pipeline – Pipeline by Phases of Development 28
5.6.1 Head and Neck Cancer Therapeutics – Regulatory and Phase III Clinical Pipeline 28
5.6.2 Head and Neck Cancer Therapeutics-Phase II Clinical Pipeline 31
5.6.3 Head and Neck Cancer Therapeutics-Phase I Clinical Pipeline 42
5.6.4 Head and Neck Cancer Therapeutics- Preclinical Pipeline 46
5.7 Discontinued / Suspended Drugs for Head and Neck Cancer 46
5.8 Key Takeaway 46
6 Head and Neck Cancer Therapeutics Market: Implications for Future Market Competition 47
7 Head and Neck Cancer Therapeutics Market: Future Players 49
7.1 Introduction 49
7.2 GlaxoSmithKline (GSK) 49
7.2.1 Overview 49
7.2.2 Oncology Pipeline Products 50
7.3 Oncolytics Biotech, Inc. 51
7.3.1 Overview 51
7.3.2 Oncology Pipeline Products 52
7.4 Biovex Inc. 52
7.4.1 Overview 52
7.4.2 Oncology Pipeline Products 52
7.5 AstraZeneca PLC 52
7.5.1 Overview 52
7.5.2 Oncology Pipeline Products 54
7.6 Advaxis, Inc. 54
7.6.1 Overview 54
7.6.2 Oncology Pipeline Products 55
7.7 TapImmune Inc. 55
7.7.1 Overview 55
7.7.2 Oncology Pipeline Products 55
7.8 IRX Therapeutics, Inc. 56
7.8.1 Overview 56
7.8.2 Oncology Pipeline Products 56
7.9 Keryx Biopharmaceuticals, Inc. 56
7.9.1 Overview 56
7.9.2 Oncology Pipeline Products 57
7.10 CEL-SCI Corporation 57
7.10.1 Overview 57
7.10.2 Oncology Pipeline Products 57
8 Head and Neck Cancer Market: Appendix 58
8.1 Market Definitions 58
8.2 Scope of Pipeline Research 58
8.3 Abbreviations 58
8.4 Research Methodology 60
8.4.1 Coverage 60
8.4.2 Secondary Research 60
8.4.3 Forecasting 60
8.4.4 Primary Research 63
8.4.5 Expert Panels 63
8.5 Contact Us 63
8.6 Disclaimer 64
8.7 Sources 64
ABBREVIATIONS
Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports:
Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010
http://www.sandlerresearch.org/Reports/36435-colorectal-cancer-global-drug-forecasts-and-treatment-analysis-.html
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html
Drug Delivery: Heading Towards A Needle Free Future
http://www.sandlerresearch.org/Reports/14862-drug-delivery-heading-towards-a-needle-free-future.html
Hip Resurfacing and Large Metal Head Market
http://www.sandlerresearch.org/Reports/14337-hip-resurfacing-and-large-metal-head-market.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/